Cargando…
Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895602/ https://www.ncbi.nlm.nih.gov/pubmed/33628541 http://dx.doi.org/10.1155/2021/2361360 |
| _version_ | 1783653389317439488 |
|---|---|
| author | Alonso-Bello, Cesar Daniel Jiménez-Martínez, María del Carmen Vargas-Camaño, María Eugenia Hierro-Orozco, Sagrario Ynga-Durand, Mario Alberto Berrón-Ruiz, Laura Alcántara-Montiel, Julio César Santos-Argumedo, Leopoldo Andrea Herrera-Sánchez, Diana Lozano-Patiño, Fernando Castrejón-Vázquez, María Isabel |
| author_facet | Alonso-Bello, Cesar Daniel Jiménez-Martínez, María del Carmen Vargas-Camaño, María Eugenia Hierro-Orozco, Sagrario Ynga-Durand, Mario Alberto Berrón-Ruiz, Laura Alcántara-Montiel, Julio César Santos-Argumedo, Leopoldo Andrea Herrera-Sánchez, Diana Lozano-Patiño, Fernando Castrejón-Vázquez, María Isabel |
| author_sort | Alonso-Bello, Cesar Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7895602 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78956022021-02-23 Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” Alonso-Bello, Cesar Daniel Jiménez-Martínez, María del Carmen Vargas-Camaño, María Eugenia Hierro-Orozco, Sagrario Ynga-Durand, Mario Alberto Berrón-Ruiz, Laura Alcántara-Montiel, Julio César Santos-Argumedo, Leopoldo Andrea Herrera-Sánchez, Diana Lozano-Patiño, Fernando Castrejón-Vázquez, María Isabel Case Reports Immunol Erratum Hindawi 2021-01-31 /pmc/articles/PMC7895602/ /pubmed/33628541 http://dx.doi.org/10.1155/2021/2361360 Text en Copyright © 2021 Cesar Daniel Alonso-Bello et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Erratum Alonso-Bello, Cesar Daniel Jiménez-Martínez, María del Carmen Vargas-Camaño, María Eugenia Hierro-Orozco, Sagrario Ynga-Durand, Mario Alberto Berrón-Ruiz, Laura Alcántara-Montiel, Julio César Santos-Argumedo, Leopoldo Andrea Herrera-Sánchez, Diana Lozano-Patiño, Fernando Castrejón-Vázquez, María Isabel Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title | Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title_full | Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title_fullStr | Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title_full_unstemmed | Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title_short | Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” |
| title_sort | erratum to “partial and transient clinical response to omalizumab in il-21-induced low stat3-phosphorylation on hyper-ige syndrome” |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895602/ https://www.ncbi.nlm.nih.gov/pubmed/33628541 http://dx.doi.org/10.1155/2021/2361360 |
| work_keys_str_mv | AT alonsobellocesardaniel erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT jimenezmartinezmariadelcarmen erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT vargascamanomariaeugenia erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT hierroorozcosagrario erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT yngadurandmarioalberto erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT berronruizlaura erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT alcantaramontieljuliocesar erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT santosargumedoleopoldo erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT andreaherrerasanchezdiana erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT lozanopatinofernando erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome AT castrejonvazquezmariaisabel erratumtopartialandtransientclinicalresponsetoomalizumabinil21inducedlowstat3phosphorylationonhyperigesyndrome |